For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Sarepta Therapeutics Inc (NASDAQ: SRPT) closed the day trading at $124.23 down -4.34% from the previous closing price of $129.86. In other words, the price has decreased by -$4.34 from its previous closing price. On the day, 1.81 million shares were traded. SRPT stock price reached its highest trading level at $128.53 during the session, while it also had its lowest trading level at $122.64.
Ratios:
For a better understanding of SRPT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.44 and its Current Ratio is at 4.05. In the meantime, Its Debt-to-Equity ratio is 1.44 whereas as Long-Term Debt/Eq ratio is at 1.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on May 31, 2024, initiated with a Overweight rating and assigned the stock a target price of $157.
On May 28, 2024, RBC Capital Mkts Downgraded its rating to Sector Perform which previously was Outperform and also lowered its target price recommendation from $157 to $142.
Oppenheimer Upgraded its Perform to Outperform on May 14, 2024, while the target price for the stock was maintained at $180.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 02 ’24 when Murray Dallan sold 3,635 shares for $140.00 per share. The transaction valued at 508,900 led to the insider holds 18,125 shares of the business.
Boor Kathryn Jean sold 761 shares of SRPT for $93,550 on Mar 11 ’24. The Director now owns 7,516 shares after completing the transaction at $122.93 per share. On Mar 08 ’24, another insider, Wigzell Hans Lennart Rudolf, who serves as the Director of the company, sold 15,000 shares for $123.25 each. As a result, the insider received 1,848,795 and left with 22,840 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SRPT now has a Market Capitalization of 11742692352 and an Enterprise Value of 11747562496. As of this moment, Sarepta’s Price-to-Earnings (P/E) ratio for their current fiscal year is 1868.12, and their Forward P/E ratio for the next fiscal year is 12.26. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.37 while its Price-to-Book (P/B) ratio in mrq is 12.21. Its current Enterprise Value per Revenue stands at 8.371 whereas that against EBITDA is -221.673.
Stock Price History:
Over the past 52 weeks, SRPT has reached a high of $146.68, while it has fallen to a 52-week low of $55.25. The 50-Day Moving Average of the stock is -1.90%, while the 200-Day Moving Average is calculated to be 8.63%.
Shares Statistics:
Over the past 3-months, SRPT traded about 1.24M shares per day on average, while over the past 10 days, SRPT traded about 3220770 shares per day. A total of 93.73M shares are outstanding, with a floating share count of 88.76M. Insiders hold about 6.10% of the company’s shares, while institutions hold 87.21% stake in the company. Shares short for SRPT as of 1715731200 were 6560956 with a Short Ratio of 5.30, compared to 1713139200 on 4874305. Therefore, it implies a Short% of Shares Outstanding of 6560956 and a Short% of Float of 7.26.
